|
|||||
|
|
CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel‐induced cytotoxicity |
|
| Authors: | David Z. Qian Brooks L.S. Rademacher Janet Pittsenbarger Chung‐Ying Huang Anne Myrthue Celestia S. Higano Mark Garzotto Peter S. Nelson Tomasz M. Beer |
| Affiliation: | 1. Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, Oregon;2. Division of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington;3. Division of Medical Oncology, University of Washington, Seattle, Washington;4. Division of Urology, Portland VA Medical Center, Oregon Health & Science University, Portland, Oregon |
| Abstract: | |
| Keywords: | prostate cancer chemotherapy resistance CCL2 inflammation |